Announcement of TTY Biopharm's unaudited income information in February 2022
2022.3.11
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2022/03/11 | Time of announcement | 13:38:38 |
| Subject | Announcement of TTY Biopharm's unaudited income information in February 2022 | ||||
| Date of events | 2022/03/11 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2022/03/11 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $262,346 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $56,564 thousands, and a consolidated income before tax of $61,113 thousands in February 2022; net income attributed to stockholders of the company was $49,498 thousands; EPS is $0.2. Year-to-date consolidated net sales was $669,873 thousands (in NT dollars; unaudited), a consolidated operating profit was $165,439 thousands and consolidated income before tax was $177,843 thousands until February 2022; year-to-date net income attributed to stockholders of the company was $139,185 thousands; EPS is $0.56. 6.Countermeasures:N/A 7.Any other matters that need to be specified: The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||